Abbisko Therapeutics Co, Ltd

This Phase 1 trial evaluates the safety, tolerability, and how the body handles ABSK061, given as mini-tablets by mouth. Healthy adults aged 18 to 45 receive single or multiple doses to measure drug levels and any side effects. The study also checks whether taking the tablets wit…

This early-stage study tested the safety and how the body handles a new drug called ABSK061 in 40 healthy adults aged 18 to 45. Participants took the drug as minitablets, either alone or with soft foods, to see if food affects absorption. The goal was to gather basic safety and p…

This study looked at two different versions of pimicotinib capsules to see if they work the same in the body. Twenty healthy adults took a single dose of each version, and researchers measured drug levels in their blood. The goal was to understand how well the body absorbs each v…